News

Sarepta surges, Whirlpool sinks, and other early market movers
Sarepta Therapeutics stock is surging nearly 50% after the Food and Drug Administration told the company it can [lift a voluntary pause on shipments of Elevidys](http ...
Sarepta Stock Just Soared 45%. Here’s Why.
Sarepta stock jumped after the drugmaker resumed shipments of the medicine Elevidys, previously paused by request by the FDA, ...
Trending tickers: Nvidia, Sarepta, Spotify, AstraZeneca and Greggs
Shares in the AI darling were trending in pre-market trading after finishing Monday’s session almost 2% higher as retail ...
Business Wire17h
Arrowhead Pharmaceuticals Earns $100 Million Milestone from Sarepta Therapeutics
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $100 million milestone payment from ...
Sarepta Stock Drops After Downgrade and FDA Probe. The Crisis Explained.
The selloff came after the U.S. Food and Drug Administration said late Friday that it was probing the death of an 8-year-old ...
BMO Capital Cuts Sarepta Therapeutic (SRPT) PT to $25 from $50
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the most undervalued stocks to buy and hold for 3 years. On July 22, BMO ...
Explore more